We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.
$15.00 - $17.00
November 6, 2019
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,LEERINK SWANN & COMPANY
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for 89bio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277